Approaches to synthesis of ([1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammators
Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment...
Saved in:
Published in | Farmacevtičnij žurnal Vol. 3; no. 3; pp. 44 - 54 |
---|---|
Main Author | |
Format | Journal Article |
Language | English Ukrainian |
Published |
The State Expert Center of the Ministry of Health of Ukraine
29.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle.
The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents.
Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats.
Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via heterocyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification.
Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research. |
---|---|
AbstractList | Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle.
The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents.
Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats.
Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via heterocyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification.
Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research. Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle. The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents. Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats. Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via heterocyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification. Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research. |
Author | Красовська, Н. І. |
Author_xml | – sequence: 1 givenname: Н. І. orcidid: 0000-0001-5902-6596 surname: Красовська fullname: Красовська, Н. І. |
BookMark | eNp9UU1LAzEQDaJgrf0DnvaoYGp2stlujiJ-geBFT1LCbD40sk1qEg_117tV8eBBGHjzZniP4c0B2Q0xWEKOajbnwAWcMd4uKGdiMedzgDkTO2QCbb2gsoVul0x-9_tklvMrYwyg4R2ICQnn63WKqF9srkqs8iaUsfW5iq46fqpP4bRZluTxIw5xpILq5du7D1vuAwW6GU56Gz6i1xVqb3KFuVrHYkPxOFQ4AvXBDbhaYYkpH5I9h0O2sx-cksery4eLG3p3f317cX5HNTAQtHNSusa5vmVuPF7b2oBuDGuBYasFg75uOkDTCM5RWCY0WGkdyM6gQWf5lNx--5qIr2qd_ArTRkX06msQ07PCVLwerJISat63Y7mu6bmRUnDX91Y3NTMLJkcv-PbSKeacrPv1q5n6eoDaBqy2ASuuYKRiFHV_RNoXLD6GktAP_0k_AY8rjJM |
CitedBy_id | crossref_primary_10_1007_s11224_023_02251_8 |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.32352/0367-3057.3.22.05 |
DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2617-9628 |
EndPage | 54 |
ExternalDocumentID | oai_doaj_org_article_99213b63b6f84b3d9953fbbec410d709 10_32352_0367_3057_3_22_05 |
GroupedDBID | AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV CITATION GROUPED_DOAJ |
ID | FETCH-LOGICAL-c2025-8f99f4ffb60f036ce1d2c4d0620a6c502b1482ad4533a5e05c2e9ef298dadafe3 |
IEDL.DBID | DOA |
ISSN | 0367-3057 |
IngestDate | Wed Aug 27 01:17:39 EDT 2025 Tue Jul 01 00:26:41 EDT 2025 Thu Apr 24 22:58:18 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English Ukrainian |
License | http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2025-8f99f4ffb60f036ce1d2c4d0620a6c502b1482ad4533a5e05c2e9ef298dadafe3 |
ORCID | 0000-0001-5902-6596 |
OpenAccessLink | https://doaj.org/article/99213b63b6f84b3d9953fbbec410d709 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_99213b63b6f84b3d9953fbbec410d709 crossref_primary_10_32352_0367_3057_3_22_05 crossref_citationtrail_10_32352_0367_3057_3_22_05 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-29 |
PublicationDateYYYYMMDD | 2022-06-29 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-29 day: 29 |
PublicationDecade | 2020 |
PublicationTitle | Farmacevtičnij žurnal |
PublicationYear | 2022 |
Publisher | The State Expert Center of the Ministry of Health of Ukraine |
Publisher_xml | – name: The State Expert Center of the Ministry of Health of Ukraine |
SSID | ssj0002243825 |
Score | 2.1872413 |
Snippet | Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay... |
SourceID | doaj crossref |
SourceType | Open Website Enrichment Source Index Database |
StartPage | 44 |
SubjectTerms | 4]triazolo 5-c]-quіnazolin-2-yl)benzoic acids anti-inflammatory activity dimroth rearrangement heterocyclization oxidative cyclization spectral characteristics |
Title | Approaches to synthesis of ([1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammators |
URI | https://doaj.org/article/99213b63b6f84b3d9953fbbec410d709 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA_iyYu4frC6q-QgovjyTNOkrzmqKCIoHhSERUo-obtuq_a9w_Ovd6atz3fSi9DLhCQNmRnmF5L5DSG7EYNSMAmLWkomwZ3A52xkOudG2qita2kXr66zizt5ea_u50p94Zuwjh6427gjrUWS2gy-mEubeq1VGi38WSbcj7rUPYh5c4epvy2pC15wqe6iErwIUEmXMZMKQBxHs8ZhOhRiiLXr5qLSHHl_G2XOV8hyDw_pcbesH2Rh8m-V7N10_NLTAb39SJdqBnSP3nwwT0_XSHXcM4SHho5r2kwrgHdN2dA60v0_yUAM5AOW6XiF_iAq5h6eJ2WFclkxwaaPBzZUr3XpqHGlb6hp6FM9xgdFsCjQQcnAIMGG_uNRvVknd-dnt6cXrC-owJzAsrV51DrKGG3GI2yBC4kXTnqeCW4yp7iwyApqvAQMaFTgyomgQxQ698abGNINsljVVfhJqLFWu5B7bxUgqqDNKNfBZbniAceONknyvqGF69nGsejFYwGnjlYJBSqhQCUUaSFAVJvkcDbmqePa-LT3Cepp1hN5stsGsJ6it57iK-vZ-o5JfpElgUkRPGNC_yaL45dJ2AaoMrY7rVW-Adem4tk |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Approaches+to+synthesis+of+%28%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dquinazolin-2-yl%29benzoic+acids+as+potential+anti-inflammators&rft.jtitle=Farmacevti%C4%8Dnij+%C5%BEurnal&rft.au=%D0%9A%D1%80%D0%B0%D1%81%D0%BE%D0%B2%D1%81%D1%8C%D0%BA%D0%B0%2C+%D0%9D.+%D0%86.&rft.date=2022-06-29&rft.issn=0367-3057&rft.eissn=2617-9628&rft.issue=3&rft.spage=44&rft.epage=54&rft_id=info:doi/10.32352%2F0367-3057.3.22.05&rft.externalDBID=n%2Fa&rft.externalDocID=10_32352_0367_3057_3_22_05 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0367-3057&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0367-3057&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0367-3057&client=summon |